QICNX | VIHAX | QICNX / VIHAX | |
Total Expense Ratio | 0.87 | 0.17 | 512% |
Annual Report Gross Expense Ratio | 0.91 | 0.17 | 535% |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 33.281 | 25.865 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 699M | 13.4B | 5% |
Annual Yield % from dividends | 2.26 | 3.95 | 57% |
Returns for 1 year | 23.38 | 18.56 | 126% |
Returns for 3 years | 84.74 | 63.45 | 134% |
Returns for 5 years | 79.07 | 69.66 | 114% |
Returns for 10 years | 103.60 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QTOP | 31.31 | 0.22 | +0.71% |
iShares Nasdaq Top 30 Stocks ETF | |||
EQWL | 114.93 | 0.80 | +0.70% |
Invesco S&P 100 Equal Weight ETF | |||
LABD | 32.34 | 0.16 | +0.50% |
Direxion Daily S&P Biotech Bear 3X ETF | |||
BSJT | 21.54 | 0.04 | +0.19% |
Invesco BulletShares 2029 HY Corp Bd ETF | |||
ANEW | 51.26 | N/A | N/A |
ProShares MSCI Trnsfmtnl Chngs ETF |